Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic lupus erythematosus. Recognizing its various presentations

J M Von Feldt1

  • 1Division of Rheumatology, University of Pennsylvania School of Medicine, Philadelphia, USA.

Postgraduate Medicine
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International consensus for a definition of disease flare in lupus.

Lupus·2010
Same author

Managing osteoporotic fractures minimizing pain and disability.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Musculoskeletal features in systemic lupus erythematosus and their relationship with disability.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Is there a role for Chlamydia pneumoniae infection in systemic lupus erythematosus and in the associated atherosclerotic cardiovascular disease?

Clinical and experimental rheumatology·2004
Same author

Pharmacologic therapies.

Physical medicine and rehabilitation clinics of North America·1999
Same author

Managing osteoporotic fractures: minimizing pain and disability.

Revue du rhumatisme (English ed.)·1997

Systemic lupus erythematosus (SLE) is a complex autoimmune disease affecting multiple organs, primarily in women. Management ranges from anti-inflammatory drugs for mild cases to corticosteroids and cytotoxic drugs for severe systemic lupus erythematosus.

Area of Science:

  • Immunology
  • Rheumatology

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
  • Etiology involves a complex interplay of genetic predisposition, environmental factors, and immune dysregulation.
  • SLE predominantly affects women, indicating potential hormonal or genetic influences.

Purpose of the Study:

  • To provide a comprehensive overview of systemic lupus erythematosus (SLE).
  • To outline the various causative factors and clinical presentations of SLE.
  • To summarize current therapeutic strategies for managing SLE.

Main Methods:

  • Literature review of systemic lupus erythematosus (SLE) pathogenesis, clinical features, and treatment modalities.
  • Synthesis of information on genetic, environmental, and immunological factors contributing to SLE.

Related Experiment Videos

  • Categorization of SLE manifestations across multiple organ systems.

    • Main Results:

    • SLE presents with a wide spectrum of symptoms affecting skin, joints, cardiovascular, renal, pulmonary, gastrointestinal, neuropsychiatric, and hematologic systems.
    • Identified probable causative factors include genetic predisposition, complement deficiencies, antigen persistence, drug exposure, and environmental triggers.
    • Treatment approaches vary based on disease severity, utilizing nonsteroidal anti-inflammatory drugs and antimalarials for milder forms, and corticosteroids and cytotoxic agents for severe SLE.

    Conclusions:

    • Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune condition requiring a multi-faceted approach to management.
    • Early diagnosis and tailored treatment are crucial for managing the diverse manifestations of SLE.
    • Ongoing research into the pathogenesis of SLE is vital for developing more targeted therapies.